Rapid synthesis and screening of natively paired antibodies against influenza hemagglutinin stem via oPool+ display
Ouyang, W. O.; Lv, H.; Liu, W.; Mou, Z.; Lei, R.; Pholcharee, T.; Wang, Y.; Dailey, K. E.; Gopal, A. B.; Choi, D.; Ardagh, M. R.; Talmage, L.; Rodriguez, L. A.; Dai, X.; Wu, N. C.
Show abstract
Antibody discovery is crucial for developing therapeutics and vaccines as well as understanding adaptive immunity. However, the lack of approaches to synthesize antibodies with defined sequences in a high-throughput manner represents a major bottleneck in antibody discovery. Here, we presented oPool+ display, a high-throughput cell-free platform that combined oligo pool synthesis and mRNA display to rapidly construct and characterize many natively paired antibodies in parallel. As a proof-of-concept, we applied oPool+ display to probe the binding specificity of >300 uncommon influenza hemagglutinin (HA) antibodies against 9 HA variants through 16 different screens. Over 5,000 binding tests were performed in 3-5 days with further scaling potential. Follow-up structural analysis of two HA stem antibodies revealed the previously unknown versatility of IGHD3-3 gene segment in recognizing the HA stem. Overall, this study established an experimental platform that not only accelerate antibody characterization, but also enable unbiased discovery of antibody molecular signatures.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicity 98%
- Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain 98%
- An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction 97%
Similar papers in this journal
- Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies 97%
- Protective Antibodies Against Human Parainfluenza Virus Type 3 (HPIV3) Infection 97%
- Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19 95%
Similar papers in this journal
- Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike 96%
- Epistasis in the receptor binding domain of contemporary H3N2 viruses that reverted to bind sialylated diLacNAc repeats 96%
- Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination 96%
Similar papers in this journal
- Identification of a conserved neutralizing epitope present on spike proteins from all highly pathogenic coronaviruses 97%
- Hierarchical sequence-affinity landscapes shape the evolution of breadth in an anti-influenza receptor binding site antibody 96%
- Antigenic evolution of human influenza H3N2 neuraminidase is constrained by charge balancing 95%
Similar papers in this journal
- Structure and function of a cross-neutralizing influenza neuraminidase antibody that accommodates recent N2 NA Asn245 glycosylation 97%
- Full-length single-cell BCR sequencing paired with RNA sequencing reveals convergent responses to vaccination 96%
- In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.